The global coronary heart disease (CHD) diagnostic imaging device market was valued at USD 2.0 billion in 2024 and is projected to reach USD 2.96 billion by 2030, expanding at a CAGR of 6.6% between 2025 and 2030. The growth of this market is being strongly influenced by several critical factors, most notably the increasing prevalence of coronary artery diseases (CADs) and the rising adoption of early-stage diagnostic methods. With urbanization, sedentary lifestyles, rising obesity rates, and an aging global population, the incidence of cardiovascular diseases has significantly increased. This shift is compelling healthcare systems across the world to strengthen their diagnostic infrastructure and adopt advanced imaging devices for early detection and timely intervention.

According to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases remain the leading cause of mortality in the U.S., with statistics showing that one individual dies approximately every 33 seconds from cardiovascular conditions. Such alarming data highlights the urgent need for advanced and accurate diagnostic solutions to improve survival rates and reduce the overall disease burden.

The market is also characterized by a high level of technological innovation. Continuous advancements in diagnostic imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine are reshaping the landscape of cardiac diagnostics. For example, the introduction of 64-slice cardiac CT technology significantly improved diagnostic capabilities by enabling clinicians to identify coronary lesions that obstruct more than 50% of the arterial lumen. This technology has demonstrated high sensitivity, specificity, and predictive accuracy, thereby reinforcing its value as a reliable diagnostic tool in the early detection of coronary heart disease.

In terms of industry activity, the market exhibits a moderate level of mergers and acquisitions (M&A). Companies are actively engaging in strategic collaborations and acquisitions to consolidate resources, expand product portfolios, and integrate cutting-edge imaging solutions. For instance, in May 2022, GE Healthcare acquired Zionexa, a company specializing in molecular imaging technologies designed to support cardiovascular and oncology diagnostics. This acquisition enabled GE to strengthen its portfolio with next-generation imaging solutions, positioning the company to better meet the rising global demand for comprehensive cardiovascular care. Such M&A activities underline the industry’s emphasis on innovation, technological enhancement, and integrated healthcare solutions.

Key Market Trends & Insights:

  • Regional Insights: North America emerged as the leading regional market in 2024, capturing the largest revenue share of 34.9%. This dominance is attributed to several factors, including a high prevalence of cardiovascular conditions, well-established healthcare infrastructure, strong reimbursement systems, and the presence of major diagnostic imaging technology providers.
  • By Modality: In terms of imaging modalities, the nuclear medicine segment led the market in 2024 with a revenue share of 28.19%, highlighting its importance in detecting myocardial perfusion defects and evaluating coronary artery blockages. Meanwhile, the computed tomography (CT) segment is projected to record the fastest CAGR during the forecast period. CT’s growing popularity is linked to technological advancements, faster scan times, reduced radiation exposure, and its ability to generate highly accurate three-dimensional images of coronary structures.

Order a free sample PDF of the Coronary Heart Disease Diagnostic Imaging Device Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

  • 2024 Market Size: USD 2.0 Billion
  • 2030 Projected Market Size: USD 2.96 Billion
  • CAGR (2025-2030): 6.6%
  • North America: Largest market in 2024

Key Players

  • Canon
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninkilijhe Phillips N.V.
  • SAMSUNG
  • Siemens Healthineers AG
  • Ziehm Imaging GmbH

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global coronary heart disease diagnostic imaging device market is set for steady growth, fueled by the rising prevalence of cardiovascular diseases, the need for early detection, and advancements in imaging technologies such as CT, MRI, and nuclear medicine. North America leads the market due to its advanced healthcare infrastructure and high disease incidence, while CT imaging is expected to grow at the fastest pace. Strategic acquisitions, such as GE Healthcare’s purchase of Zionexa, further highlight the industry’s focus on innovation and comprehensive cardiovascular care. Overall, the market will play a critical role in enhancing diagnostic accuracy and improving patient outcomes worldwide.